Safety and Efficacy of Econazole Nitrate Foam 1% and Foam Vehicle in Subjects With Tinea Pedis
Public ClinicalTrials.gov record NCT01358240. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Randomized, Double-Blind, Vehicle Controlled, Parallel Group Comparison of Econazole Nitrate Foam 1% vs Foam Vehicle and an Evaluator-Blinded Comparison of Econazole Nitrate Foam 1% and Econazole Nitrate Cream 1% in Subjects With Interdigital Tinea Pedis
Study identification
- NCT ID
- NCT01358240
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- AmDerma
- Industry
- Enrollment
- 336 participants
Conditions and interventions
Conditions
Interventions
- Econazole Nitrate Foam 1% Drug
- Vehicle Foam Drug
- Econazole Nitrate Cream 1% Drug
- Placebo Cream Other
Drug · Other
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2011
- Primary completion
- Mar 31, 2012
- Completion
- Jul 31, 2012
- Last update posted
- Sep 27, 2012
2011 – 2012
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sunil S. Dhawan, MD | Fremont | California | 94538 | — |
| Guy F. Webster, MD, PhD | Hockessin | Delaware | 19707 | — |
| Marta I. Rendon, MD | Boca Raton | Florida | 33486 | — |
| Jonathan Kantor, MD | Jacksonville | Florida | 32204 | — |
| Steven E. Kempers, MD | Fridley | Minnesota | 55432 | — |
| Joel Schlessinger, MD | Omaha | Nebraska | 68144 | — |
| Phoebe Rich, MD | Portland | Oregon | 97210 | — |
| Edward J. Primka III, MD | Knoxville | Tennessee | 37917 | — |
| Michael T. Jarratt, MD | Austin | Texas | 78759 | — |
| William Abramovits, MD | Dallas | Texas | 75230 | — |
| David M. Pariser, MD, FAAD, FACP | Norfolk | Virginia | 23507 | — |
| Harry H. Sharata, MD, PhD | Madison | Wisconsin | 53719 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01358240, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 27, 2012 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01358240 live on ClinicalTrials.gov.